Prevention of Future Deaths reports · 2024

Joshua Delaney

Regulation 28 report to prevent future deaths, reference 2024-0189, written 8 Apr 2024. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report8 Apr 2024
Reference2024-0189
DeceasedJoshua Delaney
CoronerDavid Manknell
Coroner areaLondon Inner (South)
CategoryAlcohol, drug and medication related deaths
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

1.  National Medical Director, NHS England 

1 

CORONER 

I am David Manknell KC, Assistant Coroner, for the coroner area of London Inner South  

2 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 
and Regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 

3 

INVESTIGATION and INQUEST 

On 7 August 2020 an inquest was opened into the death of Joshua Arthur Stafford 
Delaney. The inquest was concluded on 28 March 2024.  

The medical cause of death was Propranolol toxicity. 

The jury’s conclusion at the inquest was a narrative conclusion, including a conclusion 
that the deceased took an overdose while conscious of what he was doing and that he 
intended to end his life, but that after the act he regretted his decision.  

4 

CIRCUMSTANCES OF THE DEATH 

The deceased, aged 19 at the time of his death, was a young man with a history of 
mental illness and suicidal ideation, and who had made previous suicide attempts.  

During the year prior to the index events, he had been prescribed Mirtazapine for anxiety 
and to help with sleep. Following his discharge from the Community Mental Health 
Team, he attended his GP in October 2019, with symptoms of anxiety and physical 
symptoms including palpitations and tachycardia. He was prescribed Propranolol 
 days, and given 
to be taken   times a day for 
 tablets for this purpose. He was 
given further prescriptions of 
 tablets of Propranolol at the beginning of November 
2019, and again on 4 January 2020. He had seen his GP in early December 2019, who 
had intended that the deceased move to taking Propranolol ‘as required’ in order to 
wean him off its use.  

In the early hours of 19 January 2020, the deceased took a large overdose of 
Propranolol, estimated by the toxicologist to have been 
collapsed. Despite prolonged attempts at resuscitation by the paramedics and in 
hospital, he died on 19 January 2020. 

, and was found 

5 

CORONER’S CONCERNS 

During the course of the investigation and inquest the evidence revealed matters giving 
rise to concern. In my opinion there is a risk that future deaths could occur unless action 
is taken. In the circumstances it is my statutory duty to report to you. 

The MATTERS OF CONCERN are as follows.  –  

The evidence of the General Practitioner in this case was to the effect that prior to this 
death, neither he nor his colleagues were aware that Propranolol carried any significant 
risk of death through deliberate overdose. The evidence of the doctor in question was 
that because of this specific incident, there has been a change in their approach to 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 prescribing of Propranolol at his GP surgery, with smaller quantities prescribed to 
patients who might be at risk of taking an overdose. Shortly after this incident (11 
February 2020) there was, coincidentally, an article in the British Medical Journal in 
respect of Propranolol, (“Doctors and paramedics must be better prepared to deal with 
propranolol overdoses”). However, the doctor’s evidence in the inquest was that he did 
not believe that GPs generally were currently aware of the risk of Propranolol overdoses. 

The evidence from the Consultant Psychiatrist from the Community Mental Health Team 
was that they would not usually prescribe Propranolol, and he also considered that GPs 
may not be aware of the overdose risk posed by the drug. 

The inquest also heard from the toxicologist, who gave evidence that her anecdotal 
experience was that there had in recent years been a significant number of deaths 
caused by Propranolol overdoses. 

In the circumstances, I am concerned that doctors in General Practice may not be aware 
of the risks of fatal overdose from Propranolol, and that in the absence of greater 
awareness by GPs, the prescription of quantities of Propranolol to those at risk may 
cause future deaths. 

6.  ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe you and your 
organisation have the power to take such action.  

7 

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this report, 
namely by 3 June 2024. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, setting out 
the timetable for action. Otherwise you must explain why no action is proposed. 

8 

COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner and to the following Interested 
Persons: 
and Maudsley NHS Foundation Trust, and the Metropolitan Police. 

, the South London 

I am also under a duty to send the Chief Coroner a copy of your response. 

The Chief Coroner may publish either or both in a complete or redacted or summary 
form. He may send a copy of this report to any person who he believes may find it useful 
or of interest. You may make representations to me, the coroner, at the time of your 
response, about the release or the publication of your response by the Chief Coroner. 

9 

8 April 2024                                               

2

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from NHS England (PDF)
Mr David Manknell KC 
HM Assistant Coroner  
Inner South London Coroner Area 
Southwark Coroner’s Court 
1 Tennis Street 
London  
SE1 1YD 

National Medical Director  
NHS England  
Wellington House 
133-155 Waterloo Road  
London 
SE1 8UG 

05/08/2024  

Dear Coroner, 

Re: Regulation 28 Report to Prevent Future Deaths – Joshua Arthur Stafford 
Delaney who died on 19 January 2020.  

Thank you for your Report to Prevent Future Deaths (hereafter “Report”) dated 8 April 
2024 concerning the death of Joshua Arthur Stafford Delaney on 19 January 2020. In 
advance of responding to the specific concerns raised in your Report, I would like to 
express my deep condolences to Joshua’s family and loved ones. NHS England are 
keen to assure the family and the  Coroner that the concerns raised about  Joshua’s 
care have been listened to and reflected upon.   

I am grateful for the further time granted to respond to respond to your Report, and I 
apologise for any anguish this delay may have caused Joshua’s family or friends. I 
realise that responses to Coroner Reports can form part of the important process of 
family and friends coming to terms with what has happened to their loved ones and 
appreciate this will have been an incredibly difficult time for them.  

Your Report raises the concern that doctors in General Practice may not be aware of 
the  risks  of  fatal  overdose  from  Propranolol,  and  that  in  the  absence  of  greater 
awareness by GPs, the prescription of quantities of Propranolol  to those at risk may 
cause future deaths.  

The National Institute for Health and Care Excellence (NICE) guidance on generalised 
anxiety disorder and panic disorder in adults (published on 26 January 2011) does not 
recommend the use of Propranolol in anxiety and there is no recommendation in the 
British National Formulary (BNF), which provides key information for prescribers on 
the  selection,  prescribing,  dispensing  and  administration  of  medicines,  to  use 
Propranolol for the treatment of anxiety in isolation.  The BNF does however provide 
dose  information  for  Propranolol  for  the  treatment  of  anxiety  symptoms  such  as 
palpitation, sweating and tremor, reflecting the licensed dose for these indications and 
including information on the risk of overdose from  Propranolol. Under the ‘important 
safety  information’  section,  there  is  also  reference  to  the  Health  Services  Safety 
Investigations  Body  (HSSIB)  patient  safety  investigation  from  February  2020, 
regarding the potential under-recognised risk of harm from the use of Propranolol. 

My colleagues from NHS England’s National Patient Safety Team have been engaging 
with NICE to flag the circumstances of Joshua’s death and inviting them to strengthen 
their cautions around the use of Propranolol.  

                                                                                                                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Following our review of this case, it has also been agreed that NHS England will issue 
communications  to  GPs  to  reiterate  that  NICE  do not  recommend  Propranolol as  a 
treatment option for anxiety, and emphasising the risks involved in its administration, 
and we will do so as soon as practicable. NHS England are also engaging with the 
Medicines  &  Healthcare  Products  Regulatory  Agency  (MHRA),  who  we  understand 
are also considering some communications on this issue. NHS England are happy to 
update the Coroner in due course and once communications have been issued.   

I  would  also  like  to  provide  further  assurances  on  the  national  NHS  England  work 
taking  place around  the  Reports  to  Prevent Future  Deaths.  All  reports received  are 
discussed  by  the  Regulation  28  Working  Group,  comprising  Regional  Medical 
Directors,  and  other  clinical  and  quality  colleagues  from  across  the  regions.  This 
ensures  that  key  learnings  and  insights  around  events,  such  as  the  sad  death  of 
Joshua, are shared across the NHS at both a national and regional level and helps us 
to  pay  close  attention  to  any  emerging  trends  that  may  require  further  review  and 
action.   

Thank you for bringing these important patient safety issues to my attention and please 
do not hesitate to contact me should you need any further information.  

Yours sincerely,  

National Medical Director

Related reports

Other reports by David Manknell

See all →

More reports categorised “Alcohol, drug and medication related deaths”

See all →

Track Alcohol, drug and medication related deaths

See every Prevention of Future Deaths report matching Alcohol, drug and medication related deaths, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.